A jury in Philadelphia ordered the subsidiary to pay the damages to a woman who was left chronically incontinent and with chronic pain after being implanted with a defective pelvic mesh implant, according to the report.
The plaintiff, Ella Ebaugh, received 2 Ethicon mesh implants which later eroded into her urethra, according to The Inquirer, and required 3 surgeries to remove the meshes.
The damages awarded are greater than those won by plaintiffs in 4 previously tried cases in Philadelphia as part of a mass tort program for trials related to the implants.
Previous victories included a $12.5 million award in December 2015, a $13.5 million award last February, a $20 million award this April and another $2.1 million to a Pennsylvania woman in June, according to the paper.
Ethicon told The Inquirer that it plans to appeal the verdict.
“We believe the evidence showed Ethicon’s TVT and TVT-Secur devices were properly designed, Ethicon acted appropriately and responsibly in the research, development and marketing of the products, and the products were not the cause of the plaintiff’s continuing medical problems,” Ethicon spokesperson Kristen Wallace told The Inquirer.
This year’s DeviceTalks Minnesota features four tracks packed with expertly curated content created by the industry for the industry.
ECO-SYSTEM TRACK: focuses on issues impacting medtech companies across Minnesota and beyond. TECHNOLOGY TRACK: drills down on the hottest new tech that is changing medtech. REGULATORY 201 and CLINCAL 201 TRACKS: Hosted by Medical Alley and focuses on the most important trends in regulatory and clinical development.
Take a look at our full agenda.
Use the code "TRACKS" to save 15% on the cost of registration.